Combination of a growth factor and a protease enzyme

Details Combination of a growth factor and a protease enzyme Combination of a growth factor and a protease enzyme

2007-04-10

2007-04-10

Meller, Michael (Department: 1655)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Reexamination Certificate

active

10059627

ABSTRACT:
A composition combining an extracellular matrix-degrading protease and a growth factor related to epithelial cell functions together without inactivation or degradation of the growth factor by the protease. Preferably, the protease is plasmin/plasminogen or a related one, and the growth factor is KGF or a related one. The combination associates two independent, but synergistic functions essential to the re-epithelialization process or healing process, i.e, stimulating epithelial cell proliferation/differentiation and facilitating its migration by clearing the extracellular matrix components. The combination may be constructed in various ways and can be used to treat wounds or any other disease conditions involving cells of epithelial origin or any other cell types that the growth factor may affect.

REFERENCES:
patent: 4996050 (1991-02-01), Tsukada et al.
patent: 5589451 (1996-12-01), Wilson
patent: 5631011 (1997-05-01), Wadstrom
patent: 5677278 (1997-10-01), Gospodarowicz et al.
patent: 5741642 (1998-04-01), Rubin et al.
patent: 5814605 (1998-09-01), Pierce et al.
patent: 5824643 (1998-10-01), Pierce et al.
patent: 5830879 (1998-11-01), Isner
patent: 5863767 (1999-01-01), Gospodarowicz et al.
patent: 5965530 (1999-10-01), Pierce et al.
patent: 6033664 (2000-03-01), Verheijen
patent: 6174855 (2001-01-01), Hansson
patent: 6187330 (2001-02-01), Wang et al.
patent: 6239172 (2001-05-01), Kaesemeyer
patent: 6297238 (2001-10-01), Doyle et al.
patent: 6319522 (2001-11-01), Ballard et al.
patent: 0 251 806 (1988-01-01), None
patent: 0 307 847 (1989-03-01), None
patent: 307847 (1989-03-01), None
patent: 0 357 240 (1990-03-01), None
patent: 0 619 370 (1994-10-01), None
patent: 619370 (1994-10-01), None
patent: 1 264 601 (2002-12-01), None
patent: 2 146 335 (1985-04-01), None
patent: WO 8203772 (1982-11-01), None
patent: WO 97/13857 (1997-04-01), None
patent: WO 98/16243 (1998-04-01), None
Aaronson, Stuart A., et al., “Keratinocyte Growth Factor. A Fibroblast Growth Factor Family Member with Unusual Target Cell Specificity”, Annals of the New York Academy of Sciences, 1991, vol. 638, pp. 62-77.
Bajaj-Elliott, Mona, et al., “Keratinocyte Growth Factor in Inflammatory Bowel Disease. Increased mRNA Transcripts in Ulcerative Colitis Compared with Crohn's Disease in Biopsies and Isolated Mucosal Myofibroblasts”, American Journal of Pathology, Nov. 5, 1997, vol. 151 (No. 5), pp. 1469-1476.
Baskin, Laurence S., et al., “Growth Factors in Bladder Wound Healing”, Journal of Urology, Jun. 1997, vol. 157, pp. 2388-2395.
Bechtel, Michael J., et al., “Upregulation of Cell-Surface-Associated Plasminogen Activation in Cultured Keratinocytes by Interleukin-1β and Tumor Necrosis Factor-α”, Experimental Cell Research, 1996, vol. 223, pp. 395-404.
Beer, Hans-Dietmar, et al., “Mouse Fibroblast Growth Factor 10: cDNA Cloning, Protein Characterization and Regulation of mRNA Expression”, Oncogene, 1997, vol. 15, pp. 2211-2218.
Bellosta, P, et al., “Cleavage of K-FGF Produces a Truncated Molecule with Increased Biological Activity and Receptor Binding Affinity”, Journal of Cell Biology, 1993, vol. 121, pp. 705-713.
Bugge, Thomas H., et al., “Loss of Fibrinogen Rescues Mice from the Pleiotropic Effects of Plasminogen Deficiency”, Cell, 1996, vol. 87, pp. 709-719.
Carmeliet, Peter, et al., “Genetic Analysis of Blood Vessel Formation Role of Endothelial Versus Smooth Muscle Cells”, Trends in Cardiovascular Medicine, 1997, vol. 7, pp. 271-281.
Carmeliet, Peter, et al., “Inhibitory Role of Plasminogen Activator Inhibitor-1 in Arterial Wound Healing and Neointima Formation—A Gene Targeting and Gene Transfer Study in Mice”. Circulation, 1997, vol. 96, pp. 3180-3191.
Carmeliet, Peter, et al., “Development and Disease in Proteinase-Deficient Mice: Role of the Plasminogen, Matrix Metalloproteinase and Coagulation System”, Thrombosis Research, 1998, vol. 91, pp. 255-285.
Chedid, Marcio, et al., “Glucocorticoids Inhibit Keratinocyte Growth Factor Production in Primary Dermal Fibroblasts”, Endocrinology, 1996, vol. 137, pp. 2232-2237.
Collen, Desire, et al., “Fibrinolysis and the Control of Hemostasis”, The Molecular Basis of Blood Diseases, Ed. G. S. Stamatoyannopoulos, A. W. Nienhuis, P. W. Majerus, and H. Varmus. Philadelphia: W. B. Saunders Co., 1994, pp. 725-752.
Collen, Desire, “The Plasminogen (Fibrinolytic) System”, Thrombosis and Haemostasis, 1999, vol. 82, pp. 259-270.
Farrell, Catherine L., et al., “Keratinocyte Growth Factor Protects Mice from Chemotherapy and Radiation-induced Gastrointestinal Injury and Mortality”, Cancer Research, 1998, vol. 58, pp. 933-939.
Fehrenbach, H., et al., “Keratinocyte Growth Factor-induced HyperPlasia of Rat Alveolar Type II Cellsin Vivois Resolved by Differentiation into Type I Cells and by Apoptosis”, European Respiratory Journal, 1999, vol. 14, pp. 534-544.
Finch, Paul W., et al., “Human KGF Is FGF-Related with Properties of a Paracrine Effector of Epithelial Cell Growth”, Science, 1989, vol. 245, pp. 752-755.
Folkman, Judah, “Seminars in Medicine of the Beth Israel Hospital, Boston, Clinical Applications of Research of Angiogenesis”, New England Journal of Medicine, 1995, vol. 333, pp. 1757-1763.
Gillis, Paul, et al., Keratinocyte Growth Factor Induces Angiogenesis and Protects Endothelial Barrier Function, Journal of Cell Science, 1999, vol. 112, pp. 2049-2057.
Helisch, Armin, et al., Therapeutic Angiogenesis in Ischemic Heart Disease, Thrombosis and Haemostasis, 1999, vol. 82, pp. 772-780.
Heymans, S., et al., “Inhibition of Plasminogen Activators or Matrix Metalloproteinases Prevents Cardiac Rupture but Impairs Therapeutic Angiogenesis and Causes Cardiac Failure”, Nature Medicine, 1999, vol. 5, pp. 1135-1142.
Hiraoka, Nobuaki, et al., “Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins”, Cell, 1998, vol. 95, pp. 365-377.
Hoffman, Richard, et al., “Wound Fluid from Venous Leg Ulcers Degrades Plasminogen and Reduces Plasmin Generation by Keratinocytes”, Journal of Investigative Dermatology, 1998, vol. 111, pp. 1140-1144.
Igarashi, Makoto, et al., “Characterization of Rcombinant Human Fibroblast Growth Factor (FGF)-10 Reveals Functional Similarities with Keratinocyte Growth Factor (FGF-7)”, The Journal of Biological Chemistry, 1998, vol. 273, pp. 13230-13235.
Jimenez, Pablo A., et al., “Keratinocyte Growth Factor-2 Accelerates Wound Healing in Incisional Wounds”, Journal of Surgical Research, 1999, vol. 81, pp. 238-242.
Johnson, Daniel E., et al., “Structural and Functional Diversity in the FGF Receptor Multigene Family”, Advances in Cancer Research, 1993, vol. 60, pp. 1-41.
Kao, Winston W., et al., “Healing of Corneal Epithelial Defects in Plasminogen-and-Fibrinogen-Deficient Mice”, Investigative Ophthalmology & Visual Science, 1998, vol. 39, pp. 502-508.
Komorowiez, Erzsebet, et al., “Fibrinolysis with Des-Kringle Derivatives of Plasmin and its Modulation by Plasma Protease Inhibitors”, Biochemistry, 1998, vol. 37, pp. 9112-9118.
Lu, Weiqin, et al., “Fibroblast Growth Factor-10. A Second Candidate Stromal to Epithelial Cell Andromedin in Prostate”, The Journal of Biological Chemistry, 1999, vol. 274, pp. 12827-12834.
Lund, Leif R., et al., “Functional Overlap between Two Classes of Matrix-degrading Proteases in Wound Healing”, The European Molecular Biology Organization Journal, 1999, vol. 18, pp. 4645-4656.
Marchese, Cinzia, et al., “Modulation of Keratinocyte Growth Factor and its Receptor in Reepithelializing Human Skin”, Journal of Experimental Medicine, 1995, vol. 182, pp. 1369-1376.
McKeehan, Wallace L., et al., “The Heparan Sulfate-Fibroblast Growth Factor Family: Diversity of Structure and Function”, Pro

Affiliated with

Also associated with

Rating

Combination of a growth factor and a protease enzyme does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of a growth factor and a protease enzyme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of a growth factor and a protease enzyme will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3724867